Calmare Therapeutics Inc. (CTTC) financial statements (2020 and earlier)

Company profile

Business Address 1375 KINGS HIGHWAY EAST
FAIRFIELD, CT 06824
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments00000
Cash and cash equivalents00000
Receivables00000
Inventory, net of allowances, customer advances and progress billings   44
Inventory   44
Prepaid expense0000
Prepaid expense and other current assets0
Other undisclosed current assets444  
Total current assets:44455
Noncurrent Assets
Property, plant and equipment00000
Other undisclosed noncurrent assets00000
Total noncurrent assets:00000
TOTAL ASSETS:44455
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities84413
Accounts payable22112
Accrued liabilities32211
Employee-related liabilities00   
Interest and dividends payable2 1  
Debt64321
Derivative instruments and hedges, liabilities00000
Deferred revenue and credits    0
Other undisclosed current liabilities46575
Total current liabilities:181512119
Noncurrent Liabilities
Long-term debt and lease obligation 00 0
Long-term debt, excluding current maturities 00 0
Total noncurrent liabilities: 00 0
Total liabilities:181512119
Stockholders' equity
Stockholders' equity attributable to parent, including:(14)(10)(8)(6)(4)
Preferred stock   0 
Common stock00000
Additional paid in capital4949484645
Accumulated deficit(63)(59)(56)(52)(50)
Warrants and rights outstanding   0 
Other undisclosed stockholders' equity attributable to parent000(0)0
Total stockholders' equity:(14)(10)(8)(6)(4)
TOTAL LIABILITIES AND EQUITY:44455

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
11111
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)(0)
Other undisclosed gross profit  (0)(0)(0)
Gross profit:11101
Operating expenses(1)(1)(1)(3)(4)
Other undisclosed operating loss(2)(2)(2)  
Operating loss:(2)(3)(2)(3)(3)
Nonoperating income
(Investment Income, Nonoperating)
  000
Interest and debt expense(1)(1)(1)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(4)(4)(3)(3)(3)
Other undisclosed income (loss) from continuing operations before income taxes (0)(0)00
Net loss available to common stockholders, diluted:(4)(4)(3)(3)(3)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(4)(4)(3)(3)(3)
Comprehensive loss, net of tax, attributable to parent:(4)(4)(3)(3)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: